Earnings release
Page 1
Press release - Regulated Information Melexis Q2 2026 results – Second quarter sales of 217.1 million EUR Intermediate declaration by the Board of Directors Ieper, Belgium – July 29th, 2026, 07.00 hrs CET CONFORM IFRS Q2 2026 Q2 2025 YOY change Q1 2026 SEQ change in k EUR (%) (%) Sales 217,058 211,589 3% 202,094 7% Gross result 87,939 82,602 6% 80,610 9% Gross Margin 40.5% 39.0% 39.9% EBIT 38,571 35,650 8% 33,174 16% EBIT in % 17.8% 16.8% 16.4% EBITDA 51,894 50,086 4% 45,765 13% EBITDA in % 23.9% 23.7% 22.6% Net result 30,776 37,805 -19% 23,094 33% Net result per share (EPS) 0.76 0.94 0.57 CAPEX 10,464 10,714 9,547 Sales for the second quarter of 2026 were 217.1 million EUR, an increase of 3% compared to the same quarter of the previous year and an increase of 7% compared to the previous quarter. The EUR/USD exchange rate evolution had a negative impact of 1% on sales compared to the same quarter of last year and no impact on sales compared to the previous quarter. The gross result was 87.9 million EUR or 40.5% of sales, an increase of 6% compared to the same quarter of last year and an increase of 9% compared to the previous quarter. R&D expenses were 13.8% of sales, G&A was at 6.7% of sales and Selling was at 2.2% of sales. The operating result was 38.6 million EUR or 17.8% of sales, an increase of 8% compared to the same quarter of last year and an increase of 16% compared to the previous quarter. The net result was 30.8 million EUR or 0.76 EUR per share, a decrease of 19% compared to 37.8 million EUR or 0.94 EUR per share in the second quarter of 2025 and an increase of 33% compared to the previous quarter. 1 Melexis Financial Press Release Regulated Information
Page 2
CONFORM IFRS HY 2026 HY 2025 YOY change in k EUR (%) Sales 419,152 409,837 2% Gross result 168,548 158,282 6% Gross Margin 40.2% 38.6% EBIT 71,745 64,634 11% EBIT in % 17.1% 15.8% EBITDA 97,659 91,343 7% EBITDA in % 23.3% 22.3% Net result 53,869 62,403 -14% Net result per share (EPS) 1.33 1.54 CAPEX 20,011 16,354 Sales for the first half year of 2026 were 419.2 million EUR, an increase of 2% compared to the first half year of 2025. The EUR/USD exchange rate evolution had a negative impact of 2% on sales compared to the first half year of 2025. The gross result was 168.5 million EUR or 40.2% of sales, an increase of 6% compared to the same period last year. R&D expenses were 14.1% of sales, G&A was at 6.7% of sales and Selling was at 2.2% of sales. The operating result was 71.7 million EUR or 17.1% of sales, an increase of 11% compared to 64.6 million EUR in the same half year of 2025. The net result was 53.9 million EUR or 1.33 EUR per share, a decrease of 14% compared to 62.4 million EUR or 1.54 EUR per share in the first half year of 2025. Dividend The Board of Directors decided to pay out an interim dividend of 1.30 EUR gross per share. The Melexis shares will start trading ex-coupon on October 13, 2026 (opening of the market). The record date is October 14, 2026 (closing of the market) and the dividend will be payable as from October 15, 2026. Outlook Melexis expects sales in the third quarter of 2026 to be in the range of 220 to 225 million EUR. For the second half of 2026, Melexis expects sales to be between 445 and 455 million EUR, with a gross profit margin around 41% and an operating margin around 18%, all taking into account a EUR/USD exchange rate of 1.15 for the remainder of the year. For the full year 2026, Melexis expects CAPEX to be around 40 million EUR. Business update Sales of 217.1 million EUR in the second quarter of 2026 grew 7% sequentially and 3% versus the same period last year, resulting in first half year 2026 sales of 419.2 million EUR, above our guidance. The outperforming applications were steering & braking, and thermal management. Automotive applications represented 89% of total sales in the second quarter of 2026. New product launches in the second quarter further strengthens our offering in growing automotive trends such as electrification, premiumization and ADAS. 2 Melexis Financial Press Release Regulated Information
Page 3
Quote from CEO Marc Biron "Second quarter 2026 sales came in ahead of expectations as customer demand continued to recover. In particular, position sensors, current sensors and motor drivers grew well. We capture growth in thermal management applications across all powertrains, both in-cabin and under the hood. Elsewhere sales for steering & braking applications, as well as for solar panels, are also higher. We see the improving demand environment in our order book for the rest of the year. Turning to robotics, first half sales and second half orders are growing strongly, and opportunities nearly doubled in the second quarter with substantial growth in both China and the US. We also booked 4 solid design wins with our sense and drive products, enabling physical AI in robotics. Overall, I am encouraged by the recovery set to drive sales growth in the second half of 2026, and more sales opportunities in the structural automotive growth trends of electrification, ADAS, and premiumization, as well as new markets like robotics." The statutory auditor, EY Bedrijfsrevisoren BV, represented by Olaf Janssen, has confirmed that the review procedures, which have been substantially completed, have not revealed any material misstatement in the accounting information included in this press release as of and for the six months ended June 30, 2026. 3 Melexis Financial Press Release Regulated Information
Page 4
Financial Calendar - Dividend ex-coupon date October 13, 2026 - Dividend record date October 14, 2026 - Dividend pay date October 15, 2026 - Publication Q3 2026 Results: October 28, 2026 (at 7 hrs CET) - Publication FY 2026 Results: February 3, 2027 (at 7 hrs CET) The company’s results will be discussed in English in an audio webcast and conference call on Wednesday, July 29th, 2026 at 10:30 hrs CET. Joining this event requires registration in advance. To register for the audio webcast (no possibility to ask questions) You can register for the audio webcast by clicking here. To register for the conference call (possibility to ask questions) You can register by clicking here and filling out the requested information. After registration, you will receive the conference call number, a participant user pin, conference pin and instructions on how to join the conference call. For security purposes, all participants must register individually if they wish to join the call. For more information: Investors Investor Relations Email: investor@melexis.com Journalists Brand & Communications Email: brandcomms@melexis.com About Melexis Melexis designs, develops, and delivers edge sensor and driver solutions with a heart for people and planet. Its mission is to empower engineers to turn their ideas into applications that support the best imaginable future, one that is safe, comfortable and sustainable. Melexis specializes in powertrain, thermal management, lighting, e-brake, e-steering and battery solutions for the automotive sector. It also expands its presence in the emerging markets of sustainable world, alternative mobility, robotics, and digital health. Founded in 1989 in Belgium, Melexis has grown to employ around 2,000 people in 12 countries, delivering cutting-edge technology to customers worldwide. For more information, visit www.melexis.com or follow Melexis on LinkedIn, and YouTube. 4 Melexis Financial Press Release Regulated Information
Page 5
Disclaimer Except for those statements that report the Company's historical results, the statements being made are forward looking statements. Actual results could differ materially from those projected in the forward- looking statements. Factors which could cause actual results to differ from expectations include the following: volatility in supply and demand affecting revenues and market prices, price and availability of silicon foundry, assembly and test prices, assembly and test subcontract capacity required to meet financial targets and/or meet backlog requirements, risks and delays associated with bringing up new production capabilities or with deliveries from subcontractors, timing and market acceptance of new products, increased expenses associated with new product acceptance of new products, increased expenses associated with new product introductions of process changes, delays in developing or achieving volume production of new products, which can result in delays or failure to contribute to revenues and profits, ability of the Company to maintain its customer and vendor base and delays in and/or inability in raising additional capital. 5 Melexis Financial Press Release Regulated Information
Page 6
Consolidated income statement CONFORM IFRS Quarter ended Quarter ended Half Year ended Half Year ended Year ended 30/6/2026 30/6/2025 30/6/2026 30/6/2025 31/12/2025 in k EUR audited Sales 217,058 211,589 419,152 409,837 839,617 Cost of sales -129,120 -128,987 -250,604 -251,555 -515,608 Gross result 87,939 82,602 168,548 158,282 324,009 R&D -29,940 -28,842 -59,255 -57,236 -115,897 G&A -14,556 -13,261 -28,292 -26,773 -54,332 Selling -4,872 -4,848 -9,258 -9,639 -19,818 Operating result (EBIT) 38,571 35,650 71,745 64,634 133,963 Financial result -3,147 8,376 -7,451 7,913 1,932 Result before taxes 35,424 44,026 64,293 72,547 135,895 Income taxes -4,648 -6,221 -10,424 -10,144 -23,390 Net result 30,776 37,805 53,869 62,403 112,505 Net result per share in EUR 0.76 0.94 1.33 1.54 2.78 Consolidated statement of financial position CONFORM IFRS Half Year ended Half Year ended Year ended 30/6/2026 30/6/2025 31/12/2025 in k EUR audited Current Assets : Cash and cash equivalents 37,348 33,912 34,633 Current investments — 300 — A/R Trade 123,027 104,820 107,852 Assets for current tax 16,056 31,245 27,727 Other current assets 102,463 99,509 108,805 Inventories 270,351 287,170 300,329 Total current assets 549,245 556,956 579,347 Non-current assets : Property, plant and equipment 193,490 202,977 196,956 Leased assets 7,730 7,633 7,583 Intangible fixed assets 1,522 1,384 1,197 Other non-current assets 44,752 121,369 82,819 Deferred tax assets 34,448 37,800 35,367 Total non-current assets 281,941 371,162 323,922 Total assets 831,186 928,118 903,269 6 Melexis Financial Press Release Regulated Information
Page 7
CONFORM IFRS Half Year ended Half Year ended Year ended 30/6/2026 30/6/2025 31/12/2025 in k EUR audited Current liabilities : Derivative financial instruments 77 — 284 Current portion of LT debt 3,096 5,294 13,022 Lease liabilities 1,996 2,024 2,116 A/P trade 49,430 59,074 51,054 Accrued taxes 6,464 4,865 6,706 Short-term employee benefits accruals 23,512 20,721 22,523 Other current liabilities 6,070 4,568 5,902 Deferred income 2,862 3,072 4,445 Total current liabilities 93,506 99,617 106,052 Non current liabilities : LT debt less current portion 290,091 308,687 301,278 Lease liabilities 5,850 5,716 5,623 Deferred tax liabilities 2,945 2,318 2,673 Other non-current liabilities 3,115 3,474 3,115 Total non current liabilities 302,001 320,195 312,688 Shareholders' equity : Shareholders' capital 565 565 565 Treasury shares -59,217 -27,720 -50,031 Legal reserve 57 57 57 Retained earnings 445,159 478,630 427,102 Current period's profit 53,869 62,403 112,505 Cumulative translation adjustment -4,754 -5,628 -5,669 Equity attributable to company owners 435,679 508,305 484,529 Non controlling interests — — — Total shareholders equity 435,679 508,306 484,529 Total liabilities, shareholders' equity and minority interests 831,186 928,118 903,269 7 Melexis Financial Press Release Regulated Information
Page 8
Consolidated statement of cash flows CONFORM IFRS Quarter ended Quarter ended Half Year ended Half Year ended Year ended 30/6/2026 30/6/2025 30/6/2026 30/6/2025 31/12/2025 in k EUR audited Cash flow from operating activities Net income 30,776 37,805 53,869 62,403 112,505 Adjustments for : — Operating activities 18,484 20,508 39,197 39,083 85,266 Depreciation and amortisation 12,763 13,887 24,847 25,577 51,034 Depreciation leased assets 561 549 1,067 1,132 2,305 Other provisions — -1,089 — -1,093 -991 Deferred income -1,577 2 -1,583 995 2,369 Financial result 2,089 938 4,442 2,327 7,160 Income tax expense/income 4,648 6,221 10,424 10,144 23,390 Operating profit before working capital changes 49,259 58,313 93,066 101,486 197,771 A/R, Trade -17,102 -3,721 -14,661 -3,041 -6,063 Other current assets -606 -23,769 6,342 -43,548 -52,844 Other non current assets 20,372 22,416 38,067 42,212 80,762 Inventories 20,012 -7,901 27,097 -28,088 -44,585 A/P 2,742 2,347 -1,624 -4,129 -12,149 Employee benefit liabilities -4,189 -981 931 2,478 4,307 Other current liabilities -510 -4,630 168 -4,753 -3,418 Cash generated from operations 69,978 42,074 149,386 62,617 163,781 Interest paid -1,950 -2,485 -3,916 -4,862 -9,262 Income tax paid -12,056 -23,843 2,331 -22,969 -28,213 Cash flow from operating activities 55,971 15,746 147,801 34,786 126,306 Cash flow from investing activities Purchase of PPE and intangible assets (netted) -9,812 -7,887 -19,338 -13,442 -29,364 Interest received 50 42 103 115 178 Cash provided from investing activities -9,762 -7,845 -19,235 -13,327 -29,185 Cash flows from financing activities Proceeds/Repayment of long-and short-term debt 49,009 96,307 -21,112 100,659 100,977 Repayment leasings -556 -537 -1,107 -1,081 -2,206 Dividend payment -94,448 -95,976 -94,448 -95,976 -147,851 Acquisition own shares — -8,333 -9,186 -23,310 -45,621 Cash provided from financing activities -45,995 -8,539 -125,853 -19,709 -94,699 Effect of exchange rate changes on cash and cash equivalents -6 -292 1 -519 -469 Increase/decrease in cash and cash equivalents 208 -931 2,714 1,231 1,952 Cash at beginning of the period 37,139 34,842 34,633 32,681 32,681 Cash at the end of the period 37,348 33,912 37,348 33,912 34,633 8 Melexis Financial Press Release Regulated Information
Page 9
Sales per Geography Q2 2026 Q2 2025 HY 2026 HY 2025 FY 2025 APAC 62% 63% 61% 63% 64% Asia Pacific EMEA 30% 29% 31% 28% 28% Europe - Middle-East - Africa NALA 8% 8% 8% 8% 8% North America - Latin America TOTAL 100% 100% 100% 100% 100% 9 Melexis Financial Press Release Regulated Information